Evaluation of the Dose of African Swine Fever Virus Required to Establish Infection in Pigs Following Oral Uptake.

Bibliographic Details
Title: Evaluation of the Dose of African Swine Fever Virus Required to Establish Infection in Pigs Following Oral Uptake.
Authors: Olesen, Ann Sofie, Lazov, Christina Marie, Accensi, Francesc, Johnston, Camille Melissa, Rasmussen, Thomas Bruun, Bøtner, Anette, Lohse, Louise, Belsham, Graham J.
Source: Pathogens; Feb2025, Vol. 14 Issue 2, p119, 15p
Subject Terms: AFRICAN swine fever virus, SWINE
Abstract: African swine fever virus (ASFV) is known to be very stable within a protein-rich environment and indirect virus transmission can be mediated via oral uptake of different materials. However, experimental studies in pigs have shown that infection by ASFV via the oral route can be difficult to establish. Currently, there is a lack of studies using strict oral inoculations of pigs with different doses of ASFV. Therefore, we aimed to determine the dose of a European genotype II ASFV that is required to establish infection of pigs by the oral route. In this study, 24 pigs were divided into four groups of six. Three of the groups were fed with a low, medium or high dose of the ASFV POL/2015/Podlaskie virus. The pigs in the fourth group served as positive controls and were inoculated intranasally, just once, using the low dose of the virus. All the pigs inoculated intranasally with ASFV succumbed to the infection, while only three of the six pigs that were fed the high dose of the virus became infected. None of the 12 pigs that were fed with either the medium or low dose of the virus became infected, despite receiving up to thirteen doses each. In two of the pigs infected by intranasal inoculation, the presence of a variant form of the ASFV genome was detected. The results obtained in this study underline that ASFV infection is more difficult to establish via the oral route when compared to the intranasal route. The high dose needed in order to establish oral infection could have implications for future strategies using baited vaccines containing infectious live-attenuated ASFV. [ABSTRACT FROM AUTHOR]
Copyright of Pathogens is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:20760817
DOI:10.3390/pathogens14020119
Published in:Pathogens
Language:English